Reno- and cardioprotective molecular mechanisms of SGLT2 inhibitors beyond glycemic control: from bedside to bench.
SGLT2抑制劑在糖尿病控制之外的腎臟和心臟保護分子機制:從臨床到實驗室。
Am J Physiol Cell Physiol 2023-10-12
Comparative cardiovascular benefits of individual SGLT2 inhibitors in type 2 diabetes and heart failure: a systematic review and network meta-analysis of randomized controlled trials.
單一SGLT2抑制劑在2型糖尿病和心臟衰竭中的比較心血管益處:一項隨機對照試驗的系統性回顧和網絡荟萃分析。
Front Endocrinol (Lausanne) 2024-02-28
Sodium-Glucose Cotransporter-2 Inhibitors and Cardiovascular Protection Among Patients With Type 2 Diabetes Mellitus: A Systematic Review.
二型糖尿病患者中鈉葡萄糖共同轉運蛋白2抑制劑與心血管保護:系統性回顧。
J Diabetes Res 2024-05-20
The Off-Target Cardioprotective Mechanisms of Sodium-Glucose Cotransporter 2 Inhibitors: An Overview.
鈉-葡萄糖共轉運蛋白 2 抑制劑的非靶向心臟保護機制概述。
Int J Mol Sci 2024-07-27